University of Colorado Hemophilia & Thrombosis Center — Aurora, Colorado

University of Colorado Hemophilia & Thrombosis Center is a clinical research site located in Aurora, Colorado, United States 80045.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Colorado Hemophilia & Thrombosis Center has participated in 7 clinical trials with 1 currently active.

Therapeutic areas: Hemophilia A, Von Willebrand Disease, Hemophilia B.

Sponsors: Baxalta now part of Shire, Octapharma, Tremeau Pharmceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Colorado Hemophilia & Thrombosis Center?

University of Colorado Hemophilia & Thrombosis Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Colorado Hemophilia & Thrombosis Center conducted?

University of Colorado Hemophilia & Thrombosis Center has 7 clinical trials on record, with 1 currently active. Their work covers Hemophilia A, Von Willebrand Disease, Hemophilia B.

Is University of Colorado Hemophilia & Thrombosis Center accredited by Crixeo Health?

Yes — University of Colorado Hemophilia & Thrombosis Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Colorado Hemophilia & Thrombosis Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.